Ami Fadia
Stock Analyst at Needham
(4.95)
# 141
Out of 5,023 analysts
623
Total ratings
56%
Success rate
32%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Reiterated: Buy | $256 | $219.88 | +16.43% | 71 | Oct 2, 2026 | |
| LBRX LB Pharmaceuticals | Initiated Coverage: Buy | $68 | $36.99 | +83.83% | 1 | Oct 2, 2026 | |
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $41 → $35 | $19.95 | +75.44% | 40 | Sep 25, 2026 | |
| HRMY Harmony Biosciences Holdings | Reiterated: Buy | $50 | $39.64 | +26.14% | 54 | Sep 24, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $582 | $295.51 | +96.95% | 27 | Sep 24, 2026 | |
| ALKS Alkermes | Reiterated: Buy | $62 | $41.75 | +48.50% | 19 | Sep 21, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $66 | $37.40 | +76.47% | 12 | Sep 14, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $310 | $235.67 | +31.54% | 73 | Aug 31, 2026 | |
| MPLT MapLight Therapeutics | Rated: Buy | $45 → $43 | $9.82 | +337.88% | 9 | Aug 31, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $240 → $275 | $206.64 | +33.08% | 36 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.4999 | +900.20% | 21 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $31.02 | - | 28 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $255 → $268 | $179.25 | +49.51% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $39 | $22.94 | +70.01% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $18 | $4.07 | +342.26% | 32 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $204 | $143.18 | +42.48% | 44 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $14 | $3.38 | +314.20% | 44 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €108.00 | €71.40 | n/a | 8 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $10.28 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $9.08 | n/a | 2 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $15 | $3.34 | n/a | 3 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.60 | n/a | 6 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $14.26 | n/a | 10 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5.5 → $6 | $20.30 | n/a | 9 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $12.33 | n/a | 9 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 | $25.21 | n/a | 7 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0001 | n/a | 5 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $0.000001 | n/a | 3 | Dec 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $24 | $0.3476 | n/a | 9 | Dec 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $1.5 | $0.000001 | n/a | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $13.91 | n/a | 4 | Aug 14, 2020 |
Biogen
Oct 2, 2026
Reiterated: Buy
Price Target: $256
Current: $219.88
Upside: +16.43%
LB Pharmaceuticals
Oct 2, 2026
Initiated Coverage: Buy
Price Target: $68
Current: $36.99
Upside: +83.83%
Acadia Pharmaceuticals
Sep 25, 2026
Reiterated: Buy
Price Target: $41 → $35
Current: $19.95
Upside: +75.44%
Harmony Biosciences Holdings
Sep 24, 2026
Reiterated: Buy
Price Target: $50
Current: $39.64
Upside: +26.14%
Praxis Precision Medicines
Sep 24, 2026
Reiterated: Buy
Price Target: $582
Current: $295.51
Upside: +96.95%
Alkermes
Sep 21, 2026
Reiterated: Buy
Price Target: $62
Current: $41.75
Upside: +48.50%
Definium Therapeutics
Sep 14, 2026
Reiterated: Buy
Price Target: $66
Current: $37.40
Upside: +76.47%
Jazz Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $310
Current: $235.67
Upside: +31.54%
MapLight Therapeutics
Aug 31, 2026
Rated: Buy
Price Target: $45 → $43
Current: $9.82
Upside: +337.88%
Revolution Medicines
Aug 31, 2026
Reiterated: Buy
Price Target: $240 → $275
Current: $206.64
Upside: +33.08%
Aug 14, 2026
Reiterated: Buy
Price Target: $5
Current: $0.4999
Upside: +900.20%
Aug 11, 2026
Rated: Hold
Price Target: n/a
Current: $31.02
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $255 → $268
Current: $179.25
Upside: +49.51%
Aug 6, 2026
Reiterated: Buy
Price Target: $32 → $39
Current: $22.94
Upside: +70.01%
Aug 5, 2026
Reiterated: Buy
Price Target: $11 → $18
Current: $4.07
Upside: +342.26%
Jul 31, 2026
Rated: Buy
Price Target: $200 → $204
Current: $143.18
Upside: +42.48%
Jul 30, 2026
Reiterated: Buy
Price Target: $15 → $14
Current: $3.38
Upside: +314.20%
Apr 25, 2025
Reiterated: Buy
Price Target: €108.00
Current: €71.40
Upside: n/a
Dec 14, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $10.28
Upside: n/a
Mar 10, 2021
Reiterated: Buy
Price Target: $10 → $7
Current: $9.08
Upside: n/a
Mar 8, 2021
Reiterated: Buy
Price Target: $10 → $15
Current: $3.34
Upside: n/a
Mar 2, 2021
Rated: Hold
Price Target: n/a
Current: $17.60
Upside: n/a
Mar 1, 2021
Rated: Buy
Price Target: $63
Current: $14.26
Upside: n/a
Feb 26, 2021
Rated: Hold
Price Target: $5.5 → $6
Current: $20.30
Upside: n/a
Feb 25, 2021
Rated: Buy
Price Target: $16
Current: $12.33
Upside: n/a
Feb 25, 2021
Rated: Hold
Price Target: $75
Current: $25.21
Upside: n/a
Jan 11, 2021
Reiterated: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Dec 30, 2020
Reiterated: Buy
Price Target: $10 → $7
Current: $0.000001
Upside: n/a
Dec 2, 2020
Reiterated: Buy
Price Target: $19 → $24
Current: $0.3476
Upside: n/a
Oct 1, 2020
Reiterated: Hold
Price Target: $1 → $1.5
Current: $0.000001
Upside: n/a
Aug 14, 2020
Reiterated: Buy
Price Target: $8 → $9
Current: $13.91
Upside: n/a